A review of the long-term protection after hepatitis A and B vaccination.
about
"Hepatitis" - Prevention and management in dental practiceLasting immune memory against hepatitis B in children after primary immunization with 4 doses of DTPa-HBV-IPV/Hib in the first and 2nd year of lifeImmune memory to hepatitis B persists in children aged 7-8 years, who were vaccinated in infancy with 4 doses of hexavalent DTPa-HBV-IPV/Hib (Infanrix™ hexa) vaccineConcerns regarding hepatitis B vaccination and post-vaccination test among Brazilian dentists.Factors associated with hepatitis B vaccine series completion in a randomized trial for injection drug users reached through syringe exchange programs in three US citiesLiving on three time scales: the dynamics of plasma cell and antibody populations illustrated for hepatitis a virus.Seroprevalence of hepatitis B and immune response to hepatitis B vaccination in Chinese college students mainly from the rural areas of western China and born before HBV vaccination integrated into expanded program of immunization.Systems vaccinology.Prevalence of hepatitis 'B' and hepatitis 'C' among preoperative cataract patients in KarachiHepatitis A vaccines.Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity regionComparison of immunogenicity and safety of four doses and four double doses vs. standard doses of hepatitis B vaccination in HIV-infected adults: a randomized, controlled trial.HBV vaccine efficacy and detection and genotyping of vaccineé asymptomatic breakthrough HBV infection in Egypt.Percutaneous exposure incidents in nurses: Knowledge, practice and exposure to hepatitis B infection: Percutaneous exposure incidents in nursesThe persistence of anti-HBs antibody and anamnestic response 20 years after primary vaccination with recombinant hepatitis B vaccine at infancyHepatitis A and hepatitis B vaccination responses in persons with chronic hepatitis C infections: A review of the evidence and current recommendations.Hepatitis B immunization strategies: timing is everythingBivalent inactivated hepatitis A and recombinant hepatitis B vaccine.Hepatitis B: knowledge, vaccine situation and seroconversion of dentistry students of a public university.Possible Impact of 190G > A CCR2 and Δ32 CCR5 Mutations on Decrease of the HBV Vaccine Immunogenicity-A Preliminary Report.Hepatitis B and C infection in international travelers.The immunogenicity of GSK's recombinant hepatitis B vaccine in children: a systematic review of 30 years of experience.The immunogenicity and safety of GSK's recombinant hepatitis B vaccine in adults: a systematic review of 30 years of experience.Mobilising a global response to hepatitis: Lessons learned from the HIV movement.Persistence of protection of hepatitis B vaccine and response to booster immunization in 2- to 12-year-old children.British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015.United Kingdom National Guideline on the Management of the viral hepatitides A, B and C 2015.Positive HBV-NAT in a blood donor 11 years after HBV vaccination.European guideline for the management of hepatitis B and C virus infections, 2010.Variants in ABCB1, TGFB1, and XRCC1 genes and susceptibility to viral hepatitis A infection in Mexican Americans.
P2860
Q28082194-3C9E8AAB-B7C2-46D2-A3FA-B264824E8B89Q33524566-CCCC8B48-A771-4553-A371-696915D1F5A8Q33577990-4B2EE0D8-BAE6-4AA4-8327-F728AA05E2A2Q34019908-634681A5-CFBF-4CB0-A78C-48F4BCFBA948Q34067472-4737B47F-27C5-4C85-B22A-1E86E957B874Q34186939-ABA12237-F735-4DB0-B268-3D725BD600DFQ34271615-88BA10DC-0778-4209-AE0E-0F2D980C046CQ34402910-69CDB736-353F-48EF-872B-80967957FE9CQ34407269-5E51D6F4-4825-4CC8-B162-ACDD85088F8CQ34787404-D9CC69BC-63DC-40E1-8F53-98EC4DCC6250Q35033602-B80816B8-6C2E-44DA-8B35-72445959294AQ35050640-E66712E4-CE2F-4553-976D-E6E105B35ED2Q35174813-3C9B67C7-3ECC-492E-B1B1-E478AD0EF43EQ35507554-DAE4C57E-602A-4720-9678-15898587C20CQ35886424-DA771DB2-FD0E-4E13-BC60-CC61DB317772Q37021353-FE260327-7234-4AC3-BF3C-DCDA16425AE8Q37052559-3DF17C63-30FB-42D5-8FD9-930B719F0464Q37123438-FDAEEA11-2BD4-4DEE-A254-C6843480EFE8Q37347733-76882E79-BFE2-45F4-9C67-10F87B307EF9Q37678456-DA4CAF11-6051-4BA9-A7AA-8621510262CBQ38098235-6A1C4D7D-9C00-4D96-B99B-E5C327007323Q38674210-13342C2F-D932-4C73-BDE1-26F3EBB4B855Q38675773-A1F4377D-D4F8-43AB-9CFA-4F82B383E279Q38810895-D5109664-653E-4010-9589-46B0BA522215Q40057020-93252FA5-50E5-4C0E-B373-4FC92A05989CQ40560650-17C16B2D-11ED-43CF-9D11-7953302170ECQ40990518-CF0175D7-288B-4319-BA23-33FB9C335275Q44235789-F07BF023-7370-46E3-B356-DC59A67B4D94Q45370721-A63461E9-F407-4B31-A1FB-11CE7A6BADE6Q46184384-C34A8DB5-3C0B-4F6B-B185-CFCBAC497B27
P2860
A review of the long-term protection after hepatitis A and B vaccination.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
A review of the long-term protection after hepatitis A and B vaccination.
@ast
A review of the long-term protection after hepatitis A and B vaccination.
@en
A review of the long-term protection after hepatitis A and B vaccination.
@nl
type
label
A review of the long-term protection after hepatitis A and B vaccination.
@ast
A review of the long-term protection after hepatitis A and B vaccination.
@en
A review of the long-term protection after hepatitis A and B vaccination.
@nl
prefLabel
A review of the long-term protection after hepatitis A and B vaccination.
@ast
A review of the long-term protection after hepatitis A and B vaccination.
@en
A review of the long-term protection after hepatitis A and B vaccination.
@nl
P1476
A review of the long-term protection after hepatitis A and B vaccination.
@en
P356
10.1016/J.TMAID.2006.04.004
P577
2006-06-19T00:00:00Z